Eosinophilic bronchitis without asthma

International Archives of Allergy and Immunology

Volumn 147, Issue 1, 2008, Pages 1-5

  Gonlugur, Ugur ^a   Gonlugur, Tanseli Efeoglu ^a,b  

^a ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^b Canakkale State Hospital   (Turkey)

Author keywords

Asthma; Bronchitis; Eosinophil leukocytes; Eosinophilic inflammation

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE; INTERLEUKIN 13;

ASTHMA; BRONCHITIS; CELL INFILTRATION; CLINICAL FEATURE; COUGHING; DISEASE COURSE; DRUG RESPONSE; EOSINOPHIL; EOSINOPHILIC BRONCHITIS WITHOUT ASTHMA; HUMAN; LONG TERM CARE; MAST CELL; PATHOGENESIS; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESPIRATORY TRACT ASPIRATION PROCEDURE; SHORT SURVEY; SMOOTH MUSCLE; SPIROMETRY; SYSTEMATIC REVIEW; TREATMENT DURATION;

ASTHMA; BRONCHITIS; COUGH; HUMANS; PULMONARY EOSINOPHILIA;

EID: 49749144070     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128580     Document Type: Short Survey

References (32)

1. Gonlugur U, Efeoglu T: Vascular adhesion and transendothelial migration of eosinophil leukocytes. Cell Tissue Res 2004;318:473-482.
2. Gonlugur U, Gonlugur TE: Non-allergic eosinophilic inflammation. Immunol Invest 2006;35:29-45.
3. Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE: Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989;i:1346-1348.
4. Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID: Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999;160:406-410.
5. Berry MA, Hargadon B, McKenna S, Shaw D, Green RH, Brightling CE, Wardlaw AJ, Pavord ID: Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy 2005;35:598-601.
6. Brightling CE, Pavord ID: Eosinophilic bronchitis. What is it and why is it important? Clin Exp Allergy 2000;30:4-6.
7. Brightling CE, Ward R, Wardlaw AJ, Pavord ID: Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J 2000;15:682-686.
8. Park SW, Lee YM, Jang AS, Lee JH, Hwangbo Y, Kim DJ, Park CS: Development of chronic airway obstruction in patients with eosinophilic bronchitis. A prospective follow-up study. Chest 2004;125:1998-2004.
9. Fujimura M, Ogawa H, Yasui M, Matsuda T: Eosinophilic tracheobronchitis and airway cough hypersensitivity in chronic non-productive cough. Clin Exp Allergy 2000;30:41-47.
10. Gibson PG, Zlatic K, Scott J, Sewell W, Woolley K, Saltos N: Chronic cough resembles asthma with IL-5 and granulocyte macrophage colony stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol 1998;101:320-326.
11. Birring SS, Berry M, Brightling CE, Pavord ID: Eosinophilic bronchitis: clinical features, management and pathogenesis. Am J Respir Med 2003;2:169-173.
12. Bhowmik A, Seemungal TA, Sapsford RJ, Devalia JL, Wedzicha JA: Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998;53:953-956.
13. Belda J, Leigh R, Parameswaran K, O'Byrne PM, Sears MR, Hargreave FE: Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000;161:475-478.
14. Spanevello A, Confalonieri M, Sulotto F, Romano F, Balzano G, Migliori GB, Bianchi A, Michetti G: Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2000;162:1172-1174.
15. Krakowiak AM, Dudek W, Ruta U, Palczynski C: Occupational eosinophilic bronchitis without asthma due to chloramine exposure. Occup Med 2005;55:396-398.
16. Ogawa H, Fujimura M, Heki U, Kitagawa M, Matsuda T: Eosinophilic bronchitis presenting with only severe dry cough due to bucillamine. Respir Med 1995;89:219-221.
17. Di Stefano F, Di Giampaolo L, Verna N, Di Gioacchino M: Occupational eosinophilic bronchitis in a foundry worker exposed to isocyanate and a baker exposed to flour. Thorax 2007;62:368-370.
18. Yacoub MR, Malo JL, Labrecque M, Cartier A, Lemiere C: Occupational eosinophilic bronchitis. Allergy 2005;60:1542-1544.
19. Gibson PG, Fujimura M, Niimi A: Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax 2002;57:178-182.
20. Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ, Pavord ID: Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003;58:528-532.
21. Park SW, Jangm HK, An MH, Min JW, Jang AS, Lee JH, Park CS: Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis. Comparison with asthma. Chest 2005;128:1921-1927.
22. Brightling CE, Ward R, Woltmann G, Bradding P, Sheller JR, Dworski R, Pavord ID: Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000;162:878-882.
23. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID: Mast cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-1705.
24. Woodman L, Sutcliffe A, Kaur D, Berry M, Bradding P, Pavord ID, Brightling CE: Chemokine concentrations and mast cell chemotactic activity in BAL fluid in patients with eosinophilic bronchitis and asthma, and in normal control subjects. Chest 2006;130:371-378.
25. Schulman ES, MacGlashan DW, Schleimer RP, Peters SP, Kagey-Sobotka A, Newball HH, Lichtenstein LM: Purified human basophils and mast cells: current concepts of mediator release. Eur J Respir Dis 1983;128:53-61.
26. Brightling CE: Chronic cough due to nonasthmatic eosinophilic bronchitis. ACCP evidence-based clinical practice guidelines. Chest 2006;129:116S-121S.
27. Berry MA, Parker D, Neale N, Woodman L, Morgan A, Monk P, Bradding P, Wardlaw AJ, Pavord ID, Brightling CE: Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2004;114:1106-1109.
28. Thomson NC, Chaudhuri R: Why is eosinophilic bronchitis not asthma? Am J Respir Crit Care Med 2004;170:4-5.
29. Kanazawa H, Nomura S, Yoshikawa J: Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. Am J Respir Crit Care Med 2004;169:1125-1130.
30. Siddiqui S, Sutcliffe A, Shikotra A, Woodman L, Doe C, McKenna S, Wardlaw A, Bradding P, Pavord I, Brightling C: Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. J Allergy Clin Immunol 2007;120:813-819.
31. Hancox RJ, Leigh R, Kelly MM, Hargreave FE: Eosinophilic bronchitis. Lancet 2001;358:1104.
32. Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID: Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. Eur Respir J 1999;14:1228-1230.